NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
UNITED STATES |
OMB APPROVAL |
OMB Number: |
3235-0080 |
Expires: |
March 31, 2018 |
Estimated average burden |
hours per response: |
1.7 |
|
|
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
FORM 25 |
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
Commission File Number |
001-39218 |
Issuer: |
CONMED CORP |
Exchange: |
NEW YORK STOCK EXCHANGE LLC |
|
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
|
Address: |
525 French Road |
|
Utica |
NEW YORK |
13502 |
Telephone number: |
| +1.315.797.8375 |
|
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
|
Common Stock |
(Description of class of securities)
|
|
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
|
|
Pursuant to the requirements fo the Securities Exchange Act of 1934,
NEW YORK STOCK EXCHANGE LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
|
2020-05-26 |
By |
Victoria Paper |
|
Lead Analyst |
Date |
|
Name |
Title |
|
1 |
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
|
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on June 08, 2020, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on May 22, 2020, the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment.
Pursuant to the reincorporation (via merger) and change in domicile of CONMED Corporation, which became effective on May 22, 2020, each share of Common Stock of CONMED Corporation (New York) automatically converted into one share of Common Stock of CONMED Corporation (Delaware). This Form 25 is being filed solely in connection with the discontinuation of the trading on the NYSE of CONMED Corporation (New York) Common Stock and does not affect the continued listing on the NYSE of CONMED Corporation (Delaware) Common Stock.